Rare genetic variants have been studied in HGOS patients by targeted gene sequencing of TP53 [32] and in three pan-cancer cohorts including HGOS using whole-exome (WES) or whole-genome (WGS) sequencing [33,34,35]. Here, TP53 is linked to cancer.